Heregulin regulates the ability of the ErbB3-binding protein Ebp1 to bind E2F promoter elements and repress E2F-mediated transcription

被引:47
作者
Zhang, YX
Hamburger, AW
机构
[1] Univ Maryland, Sch Med, Greenebaum Canc Ctr, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA
关键词
D O I
10.1074/jbc.M314305200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The ErbB3/4 ligand heregulin (HRG) profoundly affects cell growth and differentiation, but its mechanism of action is poorly understood. Ebp1, a protein isolated by its binding to ErbB3, inhibits cell growth and represses transcription of E2F-regulated cell cycle genes. Since Ebp1 shares 38% identity with a Schizosaccharomyces pombe DNA-binding protein, we postulated that Ebp1 could bind E2F consensus elements in an HRG-inducible manner, leading to transcriptional repression. We show here that GST-Ebp1 bound to the DNA sequence bound by the S. pombe protein. Whereas GST-Ebp1 alone failed to bind E2F1 promoter elements, Ebp1 contained in nuclear lysates associated with E2F1 consensus sequences in the E2F1 promoter. Endogenous Ebp1 was recruited to the E2F1 promoter in vivo as demonstrated by chromatin immunoprecipitation assays. Ebp1 bound E2F consensus oligonucleotides in association with E2F1, retinoblastoma protein, and HDAC2. HRG regulated the association of Ebp1 with E2F promoter sequences and enhanced the ability of Ebp1 to repress transcription. Our findings suggest that Ebp1, by linking HRG activation of membrane receptors to E2F gene activity, may be a downstream modulator of the effects of HRG on cell cycle progression.
引用
收藏
页码:26126 / 26133
页数:8
相关论文
共 41 条
[21]   Regulation of E2F1 activity by acetylation [J].
Martínez-Balbás, MA ;
Bauer, UM ;
Nielsen, SJ ;
Brehm, A ;
Kouzarides, T .
EMBO JOURNAL, 2000, 19 (04) :662-671
[22]   Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor [J].
Mazumdar, A ;
Wang, RA ;
Mishra, SK ;
Adam, L ;
Bagheri-Yarmand, R ;
Mandal, M ;
Vadlamudi, RK ;
Kumar, R .
NATURE CELL BIOLOGY, 2001, 3 (01) :30-37
[23]  
Nakagawa Y, 1997, ACTA MED OKAYAMA, V51, P195
[24]   Distinct roles for phosphoinositide 3-kinase, mitogen-activated protein kinase and p38 MAPK in mediating cell cycle progression of breast cancer cells [J].
Neve, RM ;
Holbro, T ;
Hynes, NE .
ONCOGENE, 2002, 21 (29) :4567-4576
[25]   The Rb/E2F pathway and cancer [J].
Nevins, JR .
HUMAN MOLECULAR GENETICS, 2001, 10 (07) :699-703
[26]  
NEVINS JR, 1992, SCIENCE, V258, P424
[27]   The ErbB signaling network: receptor heterodimerization in development and cancer [J].
Olayioye, MA ;
Neve, RM ;
Lane, HA ;
Hynes, NE .
EMBO JOURNAL, 2000, 19 (13) :3159-3167
[28]   Heregulin inhibits proliferation via ERKs and phosphatidyl-inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells [J].
Puricelli, L ;
Proiettii, CJ ;
Labriola, L ;
Salatino, M ;
Balañá, ME ;
Ghiso, JA ;
Lupu, R ;
Pignataro, OP ;
Charreau, EH ;
Joffé, EBD ;
Elizalde, PV .
INTERNATIONAL JOURNAL OF CANCER, 2002, 100 (06) :642-653
[29]   MOLECULAR-CLONING OF A MURINE CDNA-ENCODING A NOVEL PROTEIN, P38-2G4, WHICH VARIES WITH THE CELL-CYCLE [J].
RADOMSKI, N ;
JOST, E .
EXPERIMENTAL CELL RESEARCH, 1995, 220 (02) :434-445
[30]   E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex [J].
Rayman, JB ;
Takahashi, Y ;
Indjeian, VB ;
Dannenberg, JH ;
Catchpole, S ;
Watson, RJ ;
Riele, HT ;
Dynlacht, BD .
GENES & DEVELOPMENT, 2002, 16 (08) :933-947